Time-dependent ROC curves for censored survival data and a diagnostic marker.
about
A four-marker signature of TNF-RII, TGF-α, TIMP-1 and CRP is prognostic of worse survival in high-risk surgically resected melanomaEvaluation of protein biomarkers of prostate cancer aggressivenessHigh-sensitivity ST2 for prediction of adverse outcomes in chronic heart failureStatistical controversies in clinical research: prognostic gene signatures are not (yet) useful in clinical practiceDNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsiesAn eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinomaProof of the concept to use a malignant B cell line drug screen strategy for identification and weight of melphalan resistance genes in multiple myelomaA novel miRNA-based predictive model for biochemical failure following post-prostatectomy salvage radiation therapyRisk Factors and Post-Resection Independent Predictive Score for the Recurrence of Hepatitis B-Related Hepatocellular CarcinomaIntra-tumor genetic heterogeneity and mortality in head and neck cancer: analysis of data from the Cancer Genome AtlasSelective genomic copy number imbalances and probability of recurrence in early-stage breast cancerThirty-one novel biomarkers as predictors for clinically incident diabetesGenetic predictors of medically refractory ulcerative colitisAssessment of a prognostic model, PSA metrics and toxicities in metastatic castrate resistant prostate cancer using data from Project Data Sphere (PDS)Independent associations between a metabolic syndrome severity score and future diabetes by sex and race: the Atherosclerosis Risk In Communities Study and Jackson Heart Study.Survival of Patients with Primary Brain Tumors: Comparison of Two Statistical Approaches.Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor.Plasma CXCL12 levels as a predictor of future strokeModulation of HJURP (Holliday Junction-Recognizing Protein) levels is correlated with glioblastoma cells survivalElevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients.Ultrasonic tissue characterization of carotid plaque improves the prediction of cardiovascular events in diabetic patients: a pilot studyA genetic expression profile associated with oral cancer identifies a group of patients at high risk of poor survival.Integrative analysis of DNA copy number and gene expression in metastatic oral squamous cell carcinoma identifies genes associated with poor survivalValidation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History StudyNonparametric receiver operating characteristic-based evaluation for survival outcomes.Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer.High-dimensional additive hazards regression for oral squamous cell carcinoma using microarray data: a comparative studyTest of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data.Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature.Deviance residuals-based sparse PLS and sparse kernel PLS regression for censored data.Optimal survival time-related cut-point with censored data.Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States.Explained variation for recurrent event data.NCC-AUC: an AUC optimization method to identify multi-biomarker panel for cancer prognosis from genomic and clinical data.Penalized Cox regression analysis in the high-dimensional and low-sample size settings, with applications to microarray gene expression data.Comparative study of joint analysis of microarray gene expression data in survival prediction and risk assessment of breast cancer patients.Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancerPredicting the Survival Time for Bladder Cancer Using an Additive Hazards Model in Microarray Data.EVALUATING RISK-PREDICTION MODELS USING DATA FROM ELECTRONIC HEALTH RECORDS.Quantifying the predictive performance of prognostic models for censored survival data with time-dependent covariates.
P2860
Q21245488-5F551AEB-6111-4217-B493-4386DC094B32Q21261257-D72B2C16-42BE-4489-8F17-A896933AFADCQ24610732-DC0D8D7E-E1FB-4BC5-93E6-6A02ED8E3AECQ28078729-922CB78C-9010-435A-9964-18548E3907B8Q28282708-A626915A-5E50-416B-A3A1-D6FAB1A0903FQ28388180-DD21BCCC-2EB2-475A-9E62-684F46098B2BQ28537857-E3A0100C-0670-4FF2-8A63-D4ABCF96DC3CQ28543958-F5FAD545-407F-4074-B3A6-5E9D27B83D21Q28550305-9E494761-8E27-4288-89E0-40B2AAAD3BC3Q28650140-0CCB7BF3-FACA-4EC4-A582-3C744F2D5004Q28741460-0D8ABF09-A249-42D9-8673-30C4D2C7F133Q28752614-3754A5DD-1AA1-4146-B0C7-9B541279B10EQ28943368-DA6191F9-DDA6-4D5E-936D-87D3B127EAD9Q30000285-9693B246-63A8-4B32-80E7-C87369C63BE2Q30252718-7B5DF911-80E2-40E5-8325-44633847FE14Q30390268-FC5FE347-2D3D-4BF8-BF86-E63A2A707D15Q30405581-36CDAF8F-AE84-4368-86E9-4C490A6625ADQ30416178-CA7669DF-4888-42DD-8873-D7E820412A3CQ30419684-B6882E98-75FD-4333-A648-6C60B5680106Q30422199-559F9561-E00E-4AC4-A12A-CD9380CDAA8FQ30446520-14E50D45-5B72-4A08-B174-805136B2E13FQ30487675-8C922F61-0A43-41E8-91D6-FCE5978B7A13Q30495169-02872931-94EF-44A6-A820-0B8CFA7ED8B5Q30502785-ECBC07C4-D90E-49AD-BB53-A24F258531B4Q30542862-FCD61F54-71F5-4821-8C37-4B50A7016CA6Q30574916-0F682AA8-52C9-4D88-9181-784B3D221791Q30834331-A7541387-A33A-4948-8057-7A4F4FF6D403Q30854540-89469996-75F1-46FB-9E4B-E87D0FA32628Q30854643-957AEA29-ECE8-4CCC-BE70-5993858CFC62Q30857702-C9555D8E-ED1F-4913-92DB-A324F518F682Q30868528-58A94A89-D580-4BE4-A49D-E26778AFC2A9Q30873170-CBE37218-6232-42C5-A4D8-450CA1D473BFQ30938157-66ECAC8A-E317-4585-9C25-0FD84A021DE1Q30975484-3F6DD5CD-3598-4F0E-9D72-708C3BDB4318Q30986631-8D8A4729-927D-4E50-9B26-68B4AD20C038Q31011613-B67D2365-DCAB-418F-8AA4-7755B0977B2BQ31022382-278FED12-12E3-4B55-B24F-340904BC4263Q31085072-45469593-38F9-4B03-96B1-D9657D46CECBQ31093599-11F124FA-B846-4E39-9158-04AB4B7A23C2Q31123727-96486293-BDBC-4C3E-8DEE-3A3568B40C94
P2860
Time-dependent ROC curves for censored survival data and a diagnostic marker.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Time-dependent ROC curves for censored survival data and a diagnostic marker.
@ast
Time-dependent ROC curves for censored survival data and a diagnostic marker.
@en
type
label
Time-dependent ROC curves for censored survival data and a diagnostic marker.
@ast
Time-dependent ROC curves for censored survival data and a diagnostic marker.
@en
prefLabel
Time-dependent ROC curves for censored survival data and a diagnostic marker.
@ast
Time-dependent ROC curves for censored survival data and a diagnostic marker.
@en
P2093
P1433
P1476
Time-dependent ROC curves for censored survival data and a diagnostic marker.
@en
P2093
P304
P356
10.1111/J.0006-341X.2000.00337.X
P407
P577
2000-06-01T00:00:00Z